Austism spectrum disorders: Prevalence and vaccines

Pediatric Annals

Volumn 38, Issue 1, 2009, Pages 22-25

  Peacock, Georgina ^a   Yeargin Allsopp, Marshalyn ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; THIOMERSAL;

ARTICLE; AUTISM; CHILD DEVELOPMENT; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE PERSONNEL; HUMAN; IMMUNIZATION; MEDICAL DECISION MAKING; MEDICAL EDUCATION; PEDIATRICIAN; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; TREATMENT INDICATION; CHEMICALLY INDUCED DISORDER; INFANT; UNITED STATES;

AUTISTIC DISORDER; HUMANS; INFANT; MEASLES-MUMPS-RUBELLA VACCINE; PREVALENCE; THIMEROSAL; UNITED STATES;

EID: 63049132191     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20090101-09     Document Type: Article

References (28)

1. American Academy of Pediatrics. Children's Health Topics: Childhood Vaccines, 2008. Accessed 5/6/2008 from www.aap.org/healthtopics/ immunizations.cfm.
2. Centers for Disease Control and Prevention. Vaccine Safety, 2008. Accessed 5/6/2008 from www.cdc.gov/vaccinesafety/index.htm.
3. Centers for Disease Control and Prevention. Autism Information Center, 2008. Accessed 5/6/2008 from www.cdc.gov/autism.
4. Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, six sites, United States, 2000. MMWR Surveill Summ. 2007;56(1):1-11.
5. Gordis L. Epidemiology. 2nd ed. Philadelphia, PA: W.B. Saunders Company; 2000:33.
6. Institute of Medicine (IOM). Autism and the Environment: Challenges and Opportunities for Research Workshop Proceedings. Washington DC: National Academies Press; 2008.
7. Karapurkar T, Lee N, Kresch Curran L, Newschaffer C, Yeargin-Allsopp M. The epidemiology of autism and autism spectrum disorders. In: Gupta VB, ed. Autistic Spectrum Disorders in Children. New York, NY: Marcel Dekker; 2004.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders [text revision]. 4th ed. Washington, DC: American Psychiatric Publishing; 2000.
9. Shattuck PT, Grosse SD. Issues related to the diagnosis and treatment of autism spectrum disorders. Ment Retard Dev Disabil Res Rev. 2007;13(2):129-135.
10. Rutter M. Incidence of autism spectrum disorders: Changes over time and their meaning. Acta Paediatrica. 2005;94(1):2-15.
11. Bishop DV, Whitehouse AJ, Watt HJ, Line EA. Autism and diagnostic substitution: evidence from a study of adults with a history of developmental disorder. Dev Med Child Neurol. 2008;50(5):341-345.
12. Wakefield A, Murch SH, Linnell J, et al. Illeal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351(9103):637-642.
13. Murch S, Anthony A, Casson D, et al. Retraction of an interpretation. Lancet. 2004;363(9411):750.
14. Afzal A, Ozoemena LC, O'Hare A, Kidger KA, Bentley ML, Minor PD. Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK. J Med Virol. 2006;78(5):623-630.
15. Tookey P. Rubella in England, Scotland and Wales. Euro Surveill. 2004;9(4):21-23.
16. Hornig M, Breise T, Buie T, et al. Lack of association between measles virus vaccine and autism with enteropathy: A case-control study. PLoS ONE. 2008;3(9):e3140.
17. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps and rubella vaccination and autism. N Engl J Med. 2002;347(19):1477-1482.
18. Smeeth L, Cook C, Fombonne E, et al. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet. 2004;364(9438):963-969.
19. DeStefano F, Bhasin TB, Thompson WW, Yeargin- Allsopp M, Boyle C. Age at fi rst measlesmumps- rubella vaccination in children with autism and school-matched control subjects: A population-based study in metropolitan Atlanta. Pediatrics. 2004;113(2):259-266.
20. Wilson K, Mills E, Ross C, McGowan J, Jadad A. Association of autism spectrum disorder and the measles, mumps and rubella vaccine. Arch Pediar Adolesc Med. 2003;157(7):628-634.
21. Institute of Medicine (IOM). Immunization Safety Review: Vaccines and Autism. Washington, DC; National Academies Press: 2004.
22. Baker JP. Mercury, vaccines, and autism. Am J Public Health. 2008;98(2):244-253.
23. Pichichero M, Cernichiari E, Lopreiato J, Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thimerosal: a descriptive study. Lancet. 2002;360(9347):1737-1741.
24. Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and a spectrum disorder: a critical review of published original data. Pediatrics. 2004;114(3):793-804.
25. Thompson WW, Price C, Goodson B, et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med. 2007;357(13):1281-1292.
26. Centers for Disease Control and Prevention. Immunization schedules for persons aged 0-18 Years - United States, 2008. MMWR Surveill Summ. 2007;56(51852):Q1-Q4. (Available online at http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm5701a8.htm. Accessed December 22, 2008.)
27. Diekama DS. Responding to parental refusals of immunization of children. Pediatrics. 2005;115(5):1428-1431.
28. Centers for Disease Control and Prevention. Outbreak of Measles - San Diego, California, January-February 2008. MMWR Morb Mortal Wkly Rep. 2008;57(8):203-206